Endometrial cancer laboratory findings: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Endometrial cancer}} | {{Endometrial cancer}} | ||
{{CMG}}{{AE}}{{MD}} | |||
==Overview== | ==Overview== |
Revision as of 21:05, 9 September 2015
Endometrial cancer Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Endometrial cancer laboratory findings On the Web |
American Roentgen Ray Society Images of Endometrial cancer laboratory findings |
Risk calculators and risk factors for Endometrial cancer laboratory findings |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Monalisa Dmello, M.B,B.S., M.D. [2]
Overview
The laboratory findings associated with endometrial carcinoma are the following: CBC, serum CA-125 concentration, liver function tests, and pulmonary function tests.
Colorectal Cancer Laboratory Findings
- Complete blood count and differential count - anemia
- Serum CA-125 -The tumor marker is checked, since this can predict advanced stage disease.[1]
- Hypercalcemia - with metastasis to the bone
- Abnormal liver function tests-metastasis to the liver
- Abnormal pulmonary function tests-metastasis to the lung
References
- ↑ Dotters DJ. Preoperative CA 125 in endometrial cancer: is it useful? Am J Obstet Gynecol 2000;182:1328-34. PMID 10871446.